november AG

euro adhoc: november AG
Capital measures
nvember AG proposes capital reduction for recapitalisation

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@


november AG´s management and supervisory board suggest a capital decrease at an extraordinary annual meeting aiming at supporting november AG´s n-going financial restructuring. As part of resolving november AG's on-going financial restructuring, a simpified capital decrease in accordance to §§229 ff. AktG from EUR 14.041.515,00 by way of 3 to 1 reverse stock split, in order to cover losses and cmpensation of value depreciations is suggested to the extraodinary annual meeting. The share capital of the company will be reduced by one share, which will be acquired gratuitously and collected immediately, in order to prevent share fractions. The invitation to the extraordinary annual meeting including the draft resolution is to be released to the public in the ebundesanzeiger soon.

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: november AG
Im Internet recherchierbar:

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868

Branche: Biotechnology
ISIN:      DE000A0S9N72
WKN:        A0S9N7
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade

Weitere Meldungen: november AG

Das könnte Sie auch interessieren: